key: cord-0748373-msr18cn4 authors: Shepherd, James; Friedland, Gerald title: Preventing COVID-19 collateral damage date: 2020-06-16 journal: Clin Infect Dis DOI: 10.1093/cid/ciaa772 sha: 37a79cbc44e74c59a4a1dbca55aa0aae7e8ca214 doc_id: 748373 cord_uid: msr18cn4 nan A c c e p t e d M a n u s c r i p t The world has shut down. Global commerce has screeched to a halt, the movement of people stopped and the supply of goods has slowed. As the world watched the agonies of Wuhan the virus was already spreading amongst us and left many countries with only one option -lockdown. The SARS-CoV-2 pandemic has surely been a severe reminder of the natural laws of epidemiology that still govern human society. It has sadly exacted the highest toll on the more vulnerable people in our communities. The world of public health needed no reminders of the social determinants of health. The unfair distribution of health and wealth is the shame of our planet and there are many more deadly epidemic reminders of this than the coronavirus. These communicable diseases were with us before and will be with us after the SARS-CoV-2 pandemic subsides. Progress has been made combating them but success is fragile and endangered as one of the many collateral damages wrought by COVID-19. In our compelling need to focus on COVID-19 we may lose sight of other existing epidemics and the tally of morbidity and mortality will add to and ultimately dwarf the toll of COVID-19 itself. Here's a small selection of other diseases and people that will be affected. A c c e p t e d M a n u s c r i p t Measles is a relatively old human disease. Closely related to the rinderpest virus of cattle, the current global strain probably made the inter-species jump in the 11 th Century and has caused waves of disease ever since. It's another RNA virus that makes coronavirus look like an amateur -it is spread so efficiently by the respiratory route that on average one case infects at least 15 people, compared to an estimated 2.5 by SARS-CoV-2. Spread is explosive and outbreaks amplify rapidly [1] . The illness it causes is potentially severe with a 0.2% case fatality rate reported in the USA and the WHO attributed 140000 global deaths to measles in 2018 [2]. It can cause severe illness in infants, young children and adults and in outbreaks amongst malnourished infants it can kill one in four. Before the introduction of the first vaccine in 1963 there were frequent global measles pandemics with an estimated annual death toll of 2.6 million. Because of its transmission efficiency vaccination delivery has to reach 95% of all children to achieve herd immunity. Despite the wealthier parts of the world having the irresponsible luxury of vaccine denial and tolerance for measles outbreaks, which have been increasing in the last five years, the poorer parts of the globe cannot afford this. In 2018 A c c e p t e d M a n u s c r i p t there were outbreaks of measles on every continent and 2019 was probably worse. The vaccine requires two separate doses for reliable immunity and only 69% of children received both in 2018. US CDC data from pediatrician vaccine orders and administration records measured a marked drop in measles vaccination coinciding with the COVID-19 lockdown [3] One may expect a similar drop globally as most of the world is in some form of isolation. In fact the WHO recommended that routine mass vaccination programs be halted on March 26 th [4] even amidst ongoing outbreaks of measles, most notably in the Democratic Republic of Congo. This year at least a two-month long cohort of the world's children may have no protection against this most infectious of diseases. They may face consequent morbidity and mortality that will dwarf their risks from COVID-19. Tuberculosis, also likely transmitted to humans by cattle, is amongst the oldest and most persistent of human pathogens. As with SARS-CoV-2, it is spread via respiratory secretions, with prominent fever, cough and shortness of breath, but A c c e p t e d M a n u s c r i p t the tempo of symptoms and disease and its management is far more prolongued. An estimated 25-30% of the global population (1.7-2 billion people) is infected with M. tuberculosis [5] . TB is the ninth leading cause of death globally and has surpassed HIV as the leading cause of death from a communicable disease. Globally, an estimated 10.0 million (9.0-11.1 million) people fell ill and an trade routes from Iran. Vaccine strains will definitely infect more widely in Africa in coming days, weeks and months. The elimination of the second human pathogen after smallpox seemed so close, but, as a COVID-19 collateral casualty, it will now take years more to accomplish. It takes a pathogen but also a susceptible host and an unsafe environment to generate an epidemic,. The Bronx in New York City, the Cape Flats in Cape Town, Innovative use of new practices including use of social media and communitybased telemedicine can enhance safe delivery of services. The confidence of the public must be maintained that they are visiting safe and well-managed facilities and that community vaccination or contact tracing outreach and screening and testing is conducted in a safe and respectful fashion. Where possible, shifting services from health care facilities to community settings is desirable. The supply chain must be maintained to keep PPE stocks adequate. The supply of medications and vaccines should be prioritized and maintained to avoid bottlenecks and stockouts and will involve both international and national logistics. The growing backlogs of medicines and vaccines halted by COVID-19 lockdowns must be accelerated to their destinations. This agenda requires strong Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration -United States Pandemic brings mass vaccinations to a halt The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020 The potential impact of the covid-19 response on tuberculosis in highburden countries: a modelling analysis A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t